ClariVest Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-47,191
| Closed | -$463K | – | 763 |
|
|
2017
Q1 | $463K | Sell |
47,191
-157,125
| -77% | -$1.54M | 0.01% | 394 |
|
|
2016
Q4 | $2.21M | Buy |
204,316
+9,154
| +5% | +$98.8K | 0.06% | 249 |
|
|
2016
Q3 | $2M | Buy |
195,162
+35,617
| +22% | +$365K | 0.06% | 214 |
|
|
2016
Q2 | $2.09M | Buy |
159,545
+16,600
| +12% | +$217K | 0.06% | 198 |
|
|
2016
Q1 | $1.57M | Buy |
142,945
+4,192
| +3% | +$46.1K | 0.05% | 231 |
|
|
2015
Q4 | $1.28M | Sell |
138,753
-109,363
| -44% | -$1.01M | 0.04% | 258 |
|
|
2015
Q3 | $1.72M | Sell |
248,116
-169,957
| -41% | -$1.18M | 0.05% | 202 |
|
|
2015
Q2 | $4.11M | Buy |
418,073
+33,851
| +9% | +$332K | 0.12% | 110 |
|
|
2015
Q1 | $3.4M | Buy |
384,222
+97,337
| +34% | +$862K | 0.1% | 132 |
|
|
2014
Q4 | $2.51M | Buy |
286,885
+393
| +0.1% | +$3.44K | 0.09% | 130 |
|
|
2014
Q3 | $1.98M | Buy |
+286,492
| New | +$1.98M | 0.07% | 179 |
|
|
2014
Q2 | – | Sell |
-3,253
| Closed | -$15K | – | 662 |
|
|
2014
Q1 | $15K | Sell |
3,253
-28,500
| -90% | -$131K | ﹤0.01% | 473 |
|
|
2013
Q4 | $160K | Sell |
31,753
-87,261
| -73% | -$440K | 0.01% | 378 |
|
|
2013
Q3 | $602K | Buy |
+119,014
| New | +$602K | 0.03% | 252 |
|